icn pharmaceutical lt icn seek acquisition icn pharmaceutical inc 500 mln dlrs cash another 1 50 billion dlrs available credit intend use buy pharmaceutical company chairman milan panic say company annual meet say acquisition could take place next 24 month company nearly two billion dlrs available acquisition today ," panic say add investigate number company ." one company study could possibly acquire friendly basis say panic also say intend seek board approval today repurchase three mln icn common share discuss possibility acquisition panic say purchase necessary icn current market capability would sufficient support distribution company product give icn expectation market growth worldwide icn principal product ribavirin also know virazole drug market number country describe broad base anti viral company say possible application include treatment type hepatitis herpes influenza childhood disease hemorrhagic fever icn focus consirable investor attention recent month virazole undergo clinical trial possible treatment aid relate disease panic say today would discus drug regard aid food drug administration complete review data submit company say investigation drug conduct house subcommittee continue subcommittee fda acknowledge conduct separate investigation determine whether icn witheld data fda adverse reaction drug virazole approve market u aerosol form treatment infection strike infant call respiratory syncytial virus 